(P-1077) Study of Prescribing patterns and Effectiveness of Ceftolozane/Tazobactam (C/T) Real-world Analysis (SPECTRA): Clinical Outcomes and Treatment Patterns from Mexico

Friday, October 18, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Co-Author(s)

IS

Ines Saldivar, MD

Infectious Diseases
Hospital Angeles Metropolitano
CIUDAD DE MÉXICO, Distrito Federal, Mexico
PA

Pedro Martínez Ayala, MD

Hospital Country 2000
Guadalajara, Jalisco, Mexico
AO

Adrian Camacho Ortiz, MD

HOSPITAL UNIVERSITARIO DR. JOSE ELEUTERIO GONZÁLEZ
NUEVO LEÓN, Nuevo Leon, Mexico
Paulo Castañeda-Méndez, FIDSA (he/him/his)

ID Specialist
Hospital Medica Sur
Tlalpan, Distrito Federal, Mexico
RM

Rayo Morfin-Otero, PhD

PhD
Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara
Guadalajara, Jalisco, Mexico
YZ

Yanbing Zhou, PhD

Merck
Rahway, New Jersey, United States
TP

Thales Polis, MD

MSD
Sao Paulo, Rio de Janeiro, Brazil

Emre Yucel, PhD

Principal Scientist
Merck & Co., Inc.
North Wales, Pennsylvania, United States